Kedcyla 160mg Trastuzumab Injection

 130,000

Description

Kadcyla 160mg Injection is an anti-cancer medicine. It binds to HER2 receptors on breast cancer cells and flags the cancer cells for destruction by the body’s immune system. It also goes into the cancer cells to release a chemotherapy medicine (emtansine) and stop them from growing and dividing.

Product Specification

Packaging Size1 injection
BrandKedcyla 160mg
CompositionTrastuzumab Emtansine
ManufacturerRouch (imported from Turkey)
TreatmentBreast Cancer